| Patents for C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087) |
|---|
| 08/05/2004 | US20040152896 Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination |
| 08/05/2004 | US20040152669 Anti-bacterial agents based upon oxoanion binding |
| 08/04/2004 | EP1076646B1 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 07/27/2004 | CA2124136C Method for producing benzylidene derivatives |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/06/2004 | US6759544 Antimicrobially active acesulfame complexes, process for their preparation and their use |
| 07/06/2004 | CA2060401C N-2-chlorobenzyl-2-oxo and n-2-chlorobenzyl-2, 2-dioxo-1,2,3-oxathiazolidine derivatives, their preparation and synthesis of thieno¬3,2-c|pyridine derivatives therefrom |
| 06/30/2004 | EP0971908B1 Il-8 receptor antagonists |
| 06/29/2004 | CA2171827C Use of thiazolidinediones to prevent or delay onset of niddm |
| 06/24/2004 | US20040122226 Methods for preparing N-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 05/21/2004 | WO2004041792A1 Substituted benzoxazinones and uses thereof |
| 05/21/2004 | CA2505334A1 Substituted benzoxazinones and uses thereof |
| 05/19/2004 | EP1418923A1 Anti-bacterial agents based upon oxoanion binding |
| 05/18/2004 | US6737415 Anti-bacterial agents based upon oxoanion binding |
| 05/13/2004 | WO2004039788A1 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 05/13/2004 | WO2004039785A1 Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination |
| 05/13/2004 | US20040092512 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents |
| 05/13/2004 | CA2501314A1 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 05/12/2004 | EP1417162A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 04/27/2004 | US6727359 Composition comprising 6-methyl-3,4dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide, its salts, preparation thereof and uses therefor |
| 04/21/2004 | EP1410799A1 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/15/2004 | US20040073042 Control agents for living-type free radical polymerization and methods of polymerizing |
| 04/07/2004 | EP0934289B1 Oxime derivatives and their use as fungicides |
| 04/01/2004 | WO2004026292A1 Antitussives |
| 04/01/2004 | US20040062844 Adduct of amino acid and artificial sweetener |
| 03/25/2004 | WO2003066549A3 Synthesis of sulfamidates |
| 03/11/2004 | WO2004002462A3 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 03/10/2004 | EP1395257A1 Macrocycles useful in the treatment of alzheimer's disease |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 02/25/2004 | EP1390023A2 Pharmaceutical salts |
| 02/18/2004 | EP1389184A2 Methods of preparing sulfinamide and sulfoxides |
| 01/29/2004 | US20040019056 Anititumoral analogs of et-743 |
| 01/08/2004 | WO2004002462A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 01/08/2004 | US20040006073 Method of treating attention deficit hyperactivity disorder |
| 01/08/2004 | CA2488566A1 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 12/25/2003 | US20030236240 Macrocycles useful in the treatment of alzheimer's disease |
| 12/24/2003 | WO2003067332A3 Sulfonate derivatives and the use therof as latent acids |
| 12/24/2003 | CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy |
| 12/23/2003 | US6667376 Control agents for living-type free radical polymerization and methods of polymerizing |
| 12/18/2003 | WO2002067916A3 Pharmaceutical salts |
| 12/11/2003 | US20030229054 Novel amines as pharmaceutical agents |
| 11/20/2003 | US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent |
| 11/06/2003 | WO2003091207A2 Method of preparing amine stereoisomers |
| 11/06/2003 | CA2482432A1 Method of preparing amine stereoisomers |
| 11/04/2003 | US6642251 Antitumor, 2-indolinone derivatives |
| 10/30/2003 | US20030204034 Forming a mixture of one or more monomers, at least one free radical source and a control agent and subjecting mixture to polymerization |
| 10/30/2003 | US20030203945 Coupling a heterocyclic compound containing amine group with a 4-nitrophenyl-1-oxycarbonyl or derivative useful for the treatment of neurological conditions |
| 10/23/2003 | US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 10/16/2003 | WO2002083608A3 Methods of preparing sulfinamide and sulfoxides |
| 10/16/2003 | WO2002036118A3 Heterocyclic derivatives useful as pharmaceutical agents |
| 10/09/2003 | WO2003082928A1 Control agents for living-type free radical polymerization and methods of polymerizing |
| 10/09/2003 | US20030191161 Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom |
| 09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
| 09/03/2003 | CN1440414A Synthesis of cuttlefish compound |
| 08/21/2003 | US20030158242 Salt with a sugar substitute, especially saccharin, cyclamate or acesulfame. |
| 08/20/2003 | EP1336604A1 Sulfoximine derivatives as MMP-inhibitors or antibiotics |
| 08/14/2003 | WO2003067332A2 Sulfonate derivatives and the use therof as latent acids |
| 08/14/2003 | WO2003066549A2 Synthesis of sulfamidates |
| 08/14/2003 | CA2474532A1 Sulfonate derivatives and the use therof as latent acids |
| 08/13/2003 | CN1436193A Antitumoral ecteinascidin derivs |
| 08/13/2003 | CN1117750C 3-heterocyclyl-substd. benzoyl derivs. |
| 07/31/2003 | US20030144330 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells |
| 07/31/2003 | US20030144274 Preferential enzyme inhibitors such as 3-(4-Methoxyphenyl)-prop-1-ynyl)-N-(4-carboxybenzyl)benzamide, used for prophylaxis of degenerative diseases including cancer and arthritis |
| 07/23/2003 | CN1115340C Process for synthesizing acetylsulfanilic acid and its salts |
| 06/17/2003 | US6579893 Related thiazolidinediones |
| 06/10/2003 | US6576260 Sustained-release form of administration containing tramadol saccharinate |
| 06/05/2003 | US20030105062 Anti-bacterial agents based upon oxoanion binding |
| 06/04/2003 | EP0809637B1 Fungicidal aza-heterocycloalkenes |
| 05/21/2003 | EP1311264A1 Substituted and non-substituted benzooxathiazoles and compounds derived therefrom |
| 05/21/2003 | CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 05/20/2003 | US6566547 Fungicides |
| 05/20/2003 | US6566390 Inhibiting a PTPase treating type 1 and 2 diabetes, insulin resistance and pathological obesity |
| 05/01/2003 | US20030083517 Methods of preparing sulfinamides and sulfoxides |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/23/2003 | CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/03/2003 | US20030065172 Reacting phenoxide sulfonylchloride and acetoacetamide-N-sulfonyl phenoxide and ammonia using catalyst |
| 04/02/2003 | EP0944609B1 Process for preparing n-alkyl ammonium acetonitrile compounds |
| 04/02/2003 | CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides |
| 03/26/2003 | CN1103590C Use of thiazolidinediones to prevent or delay on set of NIDDM |
| 03/12/2003 | EP1289999A1 Antitumoral analogs of et-743 |
| 03/06/2003 | WO2003018029A1 Anti-bacterial agents based upon oxoanion binding |
| 03/06/2003 | CA2455504A1 Anti-bacterial agents based upon oxoanion binding |
| 03/05/2003 | EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound |
| 03/05/2003 | CN1400208A Method for preparing 6-methyl-1,2,3-oxazine-4(3H)-ketone-2,2-dioxopotassium salt |
| 02/27/2003 | WO2003016295A1 The process for the preparation of the acesulfam salts |
| 02/27/2003 | WO2003016245A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/20/2003 | US20030035835 Protective overcoatings |
| 02/18/2003 | US6521650 Amines as pharmaceutical agents |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6517862 Containing trace elements |
| 02/05/2003 | EP1280809A1 Antitumoral ecteinascidin derivatives |
| 01/30/2003 | US20030023084 For use in the oral hygiene |
| 01/09/2003 | US20030008865 Xanthine-and phenazone-acesulfame-H complexes having improved taste, process for their preparation and their use |